Related Experiment Video
Updated: Jul 10, 2026

Inoculating and Observing Arbuscular Mycorrhizal Cultures on Superabsorbent Polymer-Based Autotrophic Systems
Published on: June 14, 2024
Infection with Scedosporium apiospermum and S. prolificans, Australia
Louise Cooley1, Denis Spelman, Karin Thursky
1Alfred Hospital, Prahran, Victoria, Australia.
Abstract:
Scedosporium apiospermum and S. prolificans are fungi of increasing clinical importance, particularly in persons with underlying diseases. We reviewed the records of 59 patients in Australia from whom Scedosporium spp. were isolated from June 30, 1997, through December 31, 2003. S. apiospermum was isolated predominantly from the respiratory tracts of 28 of 31 patients with underlying lung diseases and resulted in 2 infections and 1 death. The annual number of S. apiospermum isolates remained constant. S. prolificans was isolated from 28 patients only after November 1999. Eight patients with acute myeloid leukemia or hematopoietic stem cell transplants had invasive infection; 4 had fungemia and 6 died from infection. S. prolificans caused locally invasive infection in 2 immunocompetent patients and was found in the respiratory tract of 18 patients with underlying respiratory disease but did not cause fungemia or deaths in these patients. Scedosporium spp. showed distinct clinical and epidemiologic features.
Insights
Scedosporium apiospermum and Scedosporium prolificans are fungi causing infections, especially in immunocompromised patients. This study highlights their distinct clinical features and epidemiology in Australia.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Scedosporium apiospermum and Scedosporium prolificans are fungi with increasing clinical significance.
- These fungi pose a particular threat to individuals with compromised immune systems or underlying health conditions.
Purpose of the Study:
- To review and analyze the clinical and epidemiological features of Scedosporium species infections in Australia.
- To differentiate the distinct characteristics of S. apiospermum and S. prolificans based on patient data.
Main Methods:
- Retrospective review of medical records for 59 patients in Australia.
- Data collection spanned from June 30, 1997, to December 31, 2003.
- Analysis focused on species identification, clinical presentation, patient conditions, and outcomes.
Main Results:
- S. apiospermum was primarily isolated from respiratory tracts of patients with lung disease, causing 2 infections and 1 death.
- S. prolificans emerged after November 1999, causing invasive infections and fungemia in 8 immunocompromised patients (including those with acute myeloid leukemia and stem cell transplants), leading to 6 deaths.
- S. prolificans caused localized infections in 2 immunocompetent individuals and respiratory colonization in 18 patients with respiratory disease, without causing fungemia or mortality in this group.
Conclusions:
- Scedosporium species exhibit distinct clinical presentations and epidemiological patterns.
- S. prolificans represents a significant threat to immunocompromised hosts, particularly after 1999.
- Understanding these differences is crucial for timely diagnosis and effective management of Scedosporium infections.
Related Concept Videos
Staphylococcal Skin Infections
Fungal Phylum Microsporidia
Diversity of Protists II
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cryptococcal Meningitis
